Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Spiess

Showing results (371-380 of 566) with videos related to

Pageof 57
Sort By:
The Journal of Urology|March 21, 2015
Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched ComparisonBrian D Gonzalez, Heather S L Jim, Kristine A Donovan, et al.
Clinical Genitourinary Cancer|April 10, 2023
Variations in Penile Cancer Management: Results From the Global Society of Rare Genitourinary Tumors SurveyGagan Prakash, Amandeep Arora, Marco Bandini, et al.
Therapeutic Advances in Urology|October 31, 2019
Prognostic value of PD-L1 expression for surgically treated localized renal cell carcinoma: implications for risk stratification and adjuvant therapiesJuan Chipollini, Walter Henriques da Costa, Isabela Werneck da Cunha, et al.
Urologic Oncology|November 8, 2015
Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbiditiesScott M Haake, Samira A Brooks, Eric Welsh, et al.
Urologic Oncology|July 2, 2017
Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: A multi-institutional studyDominic H Tang, Rosa Djajadiningrat, Gregory Diorio, et al.
The Journal of Urology|June 16, 2009
Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapyLouis L Pisters, Dan Leibovici, Michael Blute, et al.
BMC Anesthesiology|November 5, 2018
Epidural anesthesia and cancer outcomes in bladder cancer patients: is it the technique or the medication? A matched-cohort analysis from a tertiary referral centerJuan Chipollini, Brandon Alford, David C Boulware, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled ComparisonBrian D Gonzalez, Heather S L Jim, Margaret Booth-Jones, et al.
Current Oncology (Toronto, Ont.)|March 28, 2023
Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical ExtensionPrithvi B Murthy, Shreyas Naidu, Facundo Davaro, et al.
European Urology Oncology|July 16, 2025
Assessing the Impact of Treatment Timing Protocols in Clinical Trials for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder CancerChristopher Guske, Seyed Behzad Jazayeri, Christian Harrs, et al.
Pageof 57

Showing results (371-380 of 566) with videos related to

Sort By:
Pageof 57
The Journal of Urology|March 21, 2015
Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched ComparisonBrian D Gonzalez, Heather S L Jim, Kristine A Donovan, et al.
Clinical Genitourinary Cancer|April 10, 2023
Variations in Penile Cancer Management: Results From the Global Society of Rare Genitourinary Tumors SurveyGagan Prakash, Amandeep Arora, Marco Bandini, et al.
Therapeutic Advances in Urology|October 31, 2019
Prognostic value of PD-L1 expression for surgically treated localized renal cell carcinoma: implications for risk stratification and adjuvant therapiesJuan Chipollini, Walter Henriques da Costa, Isabela Werneck da Cunha, et al.
Urologic Oncology|November 8, 2015
Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbiditiesScott M Haake, Samira A Brooks, Eric Welsh, et al.
Urologic Oncology|July 2, 2017
Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: A multi-institutional studyDominic H Tang, Rosa Djajadiningrat, Gregory Diorio, et al.
The Journal of Urology|June 16, 2009
Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapyLouis L Pisters, Dan Leibovici, Michael Blute, et al.
BMC Anesthesiology|November 5, 2018
Epidural anesthesia and cancer outcomes in bladder cancer patients: is it the technique or the medication? A matched-cohort analysis from a tertiary referral centerJuan Chipollini, Brandon Alford, David C Boulware, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled ComparisonBrian D Gonzalez, Heather S L Jim, Margaret Booth-Jones, et al.
Current Oncology (Toronto, Ont.)|March 28, 2023
Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical ExtensionPrithvi B Murthy, Shreyas Naidu, Facundo Davaro, et al.
European Urology Oncology|July 16, 2025
Assessing the Impact of Treatment Timing Protocols in Clinical Trials for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder CancerChristopher Guske, Seyed Behzad Jazayeri, Christian Harrs, et al.
Pageof 57